Pfg Private Wealth Management, LLC Abb Vie Inc. Transaction History

Pfg Private Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$133.59 - $154.65 $78,684 - $91,088	-589 Reduced 98.0%	12 $1,000
Q2 2023 Jul 17, 2023	BUY	$132.51 - $164.9 $36,572 - $45,512	276 Added 84.92%	601 $80,000
Q1 2023 May 01, 2023	SELL	$144.61 - $166.54 $314,092 - $361,724	-2,172 Reduced 86.98%	325 $51,000
Q4 2022 Jan 18, 2023	SELL	$138.31 - $165.87 $6,362 - $7,630	-46 Reduced 1.81%	2,497 $404,000
Q3 2022 Nov 04, 2022	BUY	$134.21 - $153.93 $229,230 - $262,912	1,708 Added 204.55%	2,543 $341,000
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $34,129 - $43,390	-248 Reduced 22.9%	835 $128,000
Q1 2022 Apr 25, 2022	BUY	$131.98 - $163.75 $141,350 - $175,376	1,071 Added 8925.0%	1,083 $176,000
Q3 2021 Nov 04, 2021	BUY	$106.4 - $120.78 $1,276 - $1,449	12 New	12 $1,000

3,943

1.26B

16.8M

12.1M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $337B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Pfg Private Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Pfg Private Wealth Management, LLC with notifications on news.